Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

European Journal of Cancer

Volumn 49, Issue 1, 2013, Pages 90-97

  Ferrand, F ^a   Malka, D ^a   Bourredjem, A ^a   Allonier, C ^a   Bouche O ^b   Louafi, S ^a   Boige, V ^a   Mousseau, M ^c   Raoul, J L ^d   Bedenne, L ^e   Leduc, B ^f   Deguiral, P ^g   Faron, M ^a   Pignon, J P ^a   Ducreux, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d CENTRE EUGÈNE MARQUIS   (France)

^e HÔPITAL DU BOCAGE   (France)

^f CH de Brive   (France)

^g Medical Oncology Unit   (France)

Author keywords

Colorectal cancer; Metastases; Multivariate analysis; Primary tumour resection

Indexed keywords

FLUOROURACIL; FOLINIC ACID; RALTITREXED;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HOSPITAL ADMISSION; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84871414810     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.07.006     Document Type: Article

References (36)

1. M.M. Center, A. Jemal, and E. Ward International trends in colorectal cancer incidence rates Cancer Epidemiol Biomarkers Prev 18 2009 1688 1694
2. Y.S. Chun, and J.N. Vauthey Extending the frontiers of resectability in advanced colorectal cancer Eur J Surg Oncol 33 Suppl. 2 2007 S52 S58
3. L. Ruo, C. Gougoutas, and P.B. Paty Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients J Am Coll Surg 196 5 2003 722 728 (Pubitemid 36560202)
4. L.E. McCahill, G.A. Yothers, and S. Sharif A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a synchronous asymptomatic primary tumor: results of NSABP C-10 J Clin Oncol 28 2010 15s [Suppl; abstr 3527]
5. A.P. Stillwell, P.G. Buettner, and Y.H. Ho Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone World J Surg 34 4 2010 797 807
6. A. Eisenberger, R.L. Whelan, and A.I. Neugut Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review Int J Colorectal Dis 23 6 2008 559 568
7. N. Damjanov, J. Weiss, and D.G. Haller Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease Oncologist 14 10 2009 963 969
8. M.G. Scheer, C.E. Sloots, and G.J. van der Wilt Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases Ann Oncol 19 11 2008 1829 1835
9. N.C. Tebbutt, A.R. Norman, and D. Cunningham Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases Gut 52 4 2003 568 573 (Pubitemid 36363413)
10. G.A. Poultsides, E.L. Servais, and L.B. Saltz Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment J Clin Oncol 27 20 2009 3379 3384
11. M. Kozloff, M.U. Yood, and J. Berlin Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study Oncologist 14 9 2009 862 870
12. B.S. Lin, A. Ziogas, and T.E. Seery Role of surgical resection among chemotherapy-treated patients with colorectal cancer stage IV disease: a survival analysis J Clin Oncol 29 2011 [Suppl; abstract 3564]
13. L.K.F. Temple, L. Hsieh, and W.D. Wong Use of surgery among elderly patients with stage IV colorectal cancer J Clin Oncol 22 17 2004 3475 3484 (Pubitemid 41103653)
14. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 23 2001 1655 1659 (Pubitemid 33126820)
15. C. Durante, H. Boukheris, and C. Dromain Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma Endocr Relat Cancer 16 2 2009 585 597
16. A. Bajwa, N. Blunt, and S. Vyas Primary tumour resection and survival in the palliative management of metastatic colorectal cancer Eur J Surg Oncol 35 2 2009 164 167
17. M.S. Kaufman, N. Radhakrishnan, and R. Roy Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study Colorectal Dis 10 5 2008 498 502 (Pubitemid 351682178)
18. M.D. Evans, X. Escofet, and S.S. Karandikar Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer World J Surg Oncol 10 2009 7 28
19. C.R. Scoggins, I.M. Meszoely, and C.D. Blanke Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 6 7 1999 651 657
20. S. Benoist, K. Pautrat, and E. Mitry Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 9 2005 1155 1160 (Pubitemid 41284882)
21. G. Galizia, E. Lieto, and M. Orditura First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases Arch Surg 143 4 2008 352 358 discussion 358 (Pubitemid 351574853)
22. M. Karoui, F. Roudot-Thoraval, and F. Mesli Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study Dis Colon Rectum 54 8 2011 930 938
23. S. Stelzner, G. Hellmich, and R. Koch Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis J Surg Oncol 89 2005 211 217 (Pubitemid 40333526)
24. S. Venderbosch, J.H. de Wilt, and S. Teerenstra Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of literature Ann Surg Oncol 18 12 2011 3252 3260
25. M. Ducreux, O. Bouché, and J.P. Pignon Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial Oncology 70 3 2006 222 230 (Pubitemid 44154696)
26. World Health Organization WHO handbook for reporting results of cancer treatment 1979 World Health Organization Geneva
27. C.H. Köhne, D. Cunningham, and C.F. Di Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients Ann Oncol 13 2 2002 308 317 (Pubitemid 34704985)
28. L. Assersohn, A. Norman, and D. Cunningham Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma Br J Cancer 79 11-12 1999 1800 1805 (Pubitemid 29132308)
29. J. Tol, M. Koopman, and C.J. Rodenburg A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity Ann Oncol 19 4 2008 734 738 (Pubitemid 351461045)
30. M. Koopman, N.F. Antonini, and J. Douma Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Lancet 370 9582 2007 135 142 (Pubitemid 47042893)
31. N.J. Petrelli Systemic chemotherapy should be the primary treatment of synchronous colorectal metastases in the asymptomatic patient [corrected] Ann Surg Oncol 13 2 2006 137 139 (Pubitemid 43157405)
32. P. Gervaz, L. Rubbia-Brandt, and A. Andres Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes Ann Surg Oncol 17 10 2010 2714 2719
33. M. Karoui, W. Koubaa, and C. Delbaldo Chemotherapy has also an effect on primary tumor in colon carcinoma Ann Surg Oncol 15 12 2008 3440 3446
34. D.Y. Heng, W. Xie, and M.M. Regan Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 34 2009 5794 5799
35. T.K. Choueiri, W. Xie, and C. Kollmannsberger The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy J Urol 185 1 2011 60 66
36. Faron M, Bourredjem A, Malka D, et al. La résection de la tumeur primitive a-t-elle un effet sur le pronostic des patients avec cancer colorectal (CCR) et métastases non résécables? Une analyse combinée sur données individuelles de quatre essais multicentriques JFHOD, 2012, Référence. CO.118.